IDYA
Price
$14.50
Change
-$0.64 (-4.23%)
Updated
Apr 8 closing price
Capitalization
1.27B
34 days until earnings call
MLTX
Price
$32.84
Change
-$1.95 (-5.61%)
Updated
Apr 8 closing price
Capitalization
2.08B
29 days until earnings call
Ad is loading...

IDYA vs MLTX

Header iconIDYA vs MLTX Comparison
Open Charts IDYA vs MLTXBanner chart's image
IDEAYA Biosciences
Price$14.50
Change-$0.64 (-4.23%)
Volume$2.35M
Capitalization1.27B
MoonLake Immunotherapeutics
Price$32.84
Change-$1.95 (-5.61%)
Volume$402.79K
Capitalization2.08B
IDYA vs MLTX Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. MLTX commentary
Apr 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and MLTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 09, 2025
Stock price -- (IDYA: $15.14 vs. MLTX: $34.78)
Brand notoriety: IDYA and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 176% vs. MLTX: 203%
Market capitalization -- IDYA: $1.27B vs. MLTX: $2.08B
IDYA [@Biotechnology] is valued at $1.27B. MLTX’s [@Biotechnology] market capitalization is $2.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both IDYA and MLTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • MLTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than MLTX.

Price Growth

IDYA (@Biotechnology) experienced а -7.57% price change this week, while MLTX (@Biotechnology) price change was -10.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.85%. For the same industry, the average monthly price growth was -20.23%, and the average quarterly price growth was -19.69%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

MLTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-9.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.08B) has a higher market cap than IDYA($1.27B). MLTX YTD gains are higher at: -35.771 vs. IDYA (-41.089). MLTX has higher annual earnings (EBITDA): -141.71M vs. IDYA (-323.14M). IDYA has more cash in the bank: 676M vs. MLTX (448M). MLTX has less debt than IDYA: MLTX (2.83M) vs IDYA (19.2M). IDYA has higher revenues than MLTX: IDYA (7M) vs MLTX (0).
IDYAMLTXIDYA / MLTX
Capitalization1.27B2.08B61%
EBITDA-323.14M-141.71M228%
Gain YTD-41.089-35.771115%
P/E RatioN/AN/A-
Revenue7M0-
Total Cash676M448M151%
Total Debt19.2M2.83M678%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
2

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAMLTX
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
43%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
60%
MACD
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
56%
Advances
ODDS (%)
Bullish Trend 28 days ago
77%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
76%
Bearish Trend 3 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
56%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME24.290.80
+3.41%
GameStop Corp
BTC.X79235.3360001020.851560
+1.31%
Bitcoin cryptocurrency
SPY504.38-0.90
-0.18%
SPDR® S&P 500® ETF
TSLA233.29-6.14
-2.56%
Tesla
AAPL181.46-6.92
-3.67%
Apple

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with RCKT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+2.92%
RCKT - IDYA
52%
Loosely correlated
+1.37%
KRYS - IDYA
51%
Loosely correlated
-3.09%
IMNM - IDYA
51%
Loosely correlated
-0.84%
DNLI - IDYA
50%
Loosely correlated
-1.53%
XENE - IDYA
50%
Loosely correlated
+4.18%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-6.53%
XENE - MLTX
44%
Loosely correlated
+4.18%
CLDX - MLTX
42%
Loosely correlated
-0.32%
DNLI - MLTX
41%
Loosely correlated
-1.53%
IDYA - MLTX
39%
Loosely correlated
+2.92%
KYMR - MLTX
38%
Loosely correlated
-0.27%
More